Evolution of interferon-beta binding antibodies in MS patients may predict development of neutralizing antibodies

被引：12
|
作者：
Mayr, M
Berek, K
Deisenhammer, F
机构：
[1] Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria
[2] Dist Hosp Kufstein, Dept Neurol, Kufstein, Austria
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2003年 / 10卷 / 04期
关键词：
antibodies; binding; interferon beta; multiple sclerosis; neutralizing;
D O I：
10.1046/j.1468-1331.2003.00608_2.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：462 / 464
页数：3
相关论文
共 50 条
  • [31] Serum Cotinine Does Not Predict Neutralizing Antibodies Against Interferon Beta in an Austrian MS Cohort
    Auer, Michael
    Hegen, Harald
    Luft, Thomas
    Bsteh, Gabriel
    Fogdell-Hahn, Anna
    Loercher, Amy
    Deisenhammer, Florian
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (12): : 667 - 670
  • [32] Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis
    Philippe Manceau
    Clotilde Latarche
    Sophie Pittion
    Gilles Edan
    Jérôme de Sèze
    Catherine Massart
    Marc Debouverie
    BMC Neurology, 14
  • [33] Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis
    Manceau, Philippe
    latarche, ClotilDe
    Pittion, Sophie
    Edan, Gilles
    de Seze, Jerome
    Massart, Catherine
    Debouverie, Marc
    BMC NEUROLOGY, 2014, 14
  • [34] Neutralising antibodies against interferon-beta neutralise natural interferon-beta
    Sominanda, A.
    Menge, T.
    Hemmer, B.
    Hartung, H. P.
    Kieseier, B. C.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S134 - S134
  • [35] The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis
    Koch-Henriksen, N.
    Sorensen, P. S.
    Bendtzen, K.
    Flachs, E. M.
    MULTIPLE SCLEROSIS, 2009, 15 (05): : 601 - 605
  • [36] Antibodies against interferon-beta in neuromyelitis optica patients
    Asgari, Nasrin
    Kyvik, Kirsten Ohm
    Steenstrup, Troels
    Stenager, Egon
    Lillevang, Soeren Thue
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 339 (1-2) : 52 - 56
  • [37] Malignant melanoma in a multiple sclerosis patient with persistent neutralizing antibodies to interferon-beta
    Gibbs, E.
    Tremlett, H.
    Ball, N.
    Hashimoto, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (01) : E4 - E4
  • [38] Antibodies to interferon beta 1b: Longitudinal studies of binding and neutralizing antibodies
    Oger, J
    Paszner, B
    Vincent, A
    Paty, DW
    NEUROLOGY, 1999, 52 (06) : A498 - A499
  • [39] Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies
    Deisenhammer, F
    Reindl, M
    Harvey, J
    Gasse, T
    Dilitz, E
    Berger, T
    NEUROLOGY, 1999, 52 (06) : 1239 - 1243
  • [40] Antibodies to commercially available interferon-beta molecules in multiple sclerosis patients treated with natural interferon-beta
    Mayorga, C
    Luque, G
    Romero, F
    Guerrero, R
    Blanca, M
    Fernandez, O
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 118 (2-4) : 368 - 371
12345